Clinical Trials Logo

Brain Injuries clinical trials

View clinical trials related to Brain Injuries.

Filter by:

NCT ID: NCT05051488 Not yet recruiting - Stroke, Acute Clinical Trials

Dynamic Decompressive Craniotomy

Start date: April 30, 2022
Phase:
Study type: Observational

Prospective observational study on patients undergoing decompressive craniotomy

NCT ID: NCT05049057 Recruiting - Clinical trials for Mild Traumatic Brain Injury

Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

Start date: July 19, 2022
Phase: Phase 2
Study type: Interventional

This study aims to assess the effect and safety of erenumab compared to placebo for the treatment of acute posttraumatic headache (PTH) in military service members and civilians with mild traumatic brain injury (mTBI).

NCT ID: NCT05048966 Recruiting - Dementia Clinical Trials

Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons

Start date: December 8, 2022
Phase: N/A
Study type: Interventional

Approximately 5.3 million people live with a long-term disability resulting from a traumatic brain injury (TBI) and between 5-8% of those older than 60 suffer from Alzheimer's disease or other forms of dementia (ADRD). Consequences of these conditions can result in dramatic and persistent changes in functioning, impacting not only the patients, but also loved ones who become informal support persons. Many existing services help the family in the moment, but do not address long-term wellness. Thus, the purpose of this research study is to compare the effect of two different types of group wellness treatments for individuals with chronic mild TBI, moderate to severe TBI, and ADRD and their support persons.

NCT ID: NCT05047003 Completed - Clinical trials for Mild Traumatic Brain Injury

Oculogica Portable EyeBOX Study

RESTLESS
Start date: December 19, 2020
Phase:
Study type: Observational

The objective of this study is to assess the accuracy of a portable version of the EyeBOX device, an eye-tracking based diagnostic, in comparison to a clinical reference standard of concussion. The utility of the portable assessment to aid in the monitoring of symptoms over time after an initial diagnosis of concussion will also be evaluated.

NCT ID: NCT05043545 Completed - Clinical trials for Traumatic Brain Injury

Long Pressure Autoregulation Index

Long PAx
Start date: March 1, 2021
Phase:
Study type: Observational

The pressure reactivity index (PRx) has emerged as a surrogate method for the continuous bedside estimation of global cerebral autoregulation and a significant predictor of unfavorable outcomes. However, calculations require continuous, high-resolution monitoring and are currently limited to specialized ICUs with dedicated software. To overcome this problem, new indices calculated using one-minute average data, instead of 10-second average data as performed by the PRx, have been proposed. The study aims to test new physiological indices appropriately modified to adapt to the scarcity of output data generated by standard hospital systems (frequency ~0.0033 Hz, approximately a 5-minute period) and to evaluate their association with outcome measures.

NCT ID: NCT05041712 Active, not recruiting - Children Clinical Trials

Biomarkers of Brain Injury in Critically-Ill Children on Extracorporeal Membrane Oxygenation

BEAM
Start date: December 6, 2019
Phase:
Study type: Observational

The BEAM study is a multicenter, prospective, observational study in children supported on extracorporeal membrane oxygenation (ECMO). The primary goals of this study are to develop and refine a brain injury multimarker panel for accurate neurologic monitoring at the bedside and early classification of mortality and disability outcomes of critically ill children supported on ECMO.

NCT ID: NCT05038930 Recruiting - Clinical trials for Subarachnoid Hemorrhage

Mobilising Patients With Severe Brain Injury in Intensive Care

MAWERIC
Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Introduction Patients with severe brain injury are often restricted to bed rest during the early period of brain injury which may lead to unwanted secondary complications. There is lack of evidence of when to initiate the first mobilisation. The Sara Combilizer® is an easy and efficient tool for mobilising patients with severe injuries, including brain injury. Through a randomised cross-over trial the investigators will investigate the impact of early mobilisation on patients with severe acquired brain injury caused by traumatic brain injury, subarachnoid brain injury or intracranial haematoma. The investigators hypothesise that mobilisation using the Sara Combilizer® does not affect partial oxygenation of brain tissue.

NCT ID: NCT05034718 Completed - Brain Injury Clinical Trials

Implementation of the Pittsburgh Infant Brain Injury Score

PIBIS
Start date: July 5, 2021
Phase: N/A
Study type: Interventional

This is an implementation study of the Pittsburgh Infant Brain Injury Score (PIBIS) into the UPMC Children's Hospital of Pittsburgh emergency department. Children less than 1 year of age presenting to the CHP ED for symptoms which place them at increased risk for AHT as defined in the PIBIS validation study will be potentially eligible.

NCT ID: NCT05033444 Recruiting - Clinical trials for Traumatic Brain Injury (TBI)

A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers

Start date: September 17, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of different dose levels of PRV-002 in Health Volunteers

NCT ID: NCT05032378 Enrolling by invitation - Stroke Clinical Trials

Motion Sensor and Feedback System Efficacy to Refine Movements After Injury

Start date: December 17, 2021
Phase:
Study type: Observational

The purpose of these case studies is to determine the efficacy of the Kinesthetic Awareness Training (KAT) device in facilitating the restoration of desired movement patterns when people with acquired central nervous system damage perform functional activities such as walking, transitioning from one position to another, or reaching with the arms.